nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—ALB—Furosemide—dilated cardiomyopathy	0.357	1	CbGbCtD
Bismuth Subsalicylate—TF—Platelet degranulation—TTN—dilated cardiomyopathy	0.0175	0.0584	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.0167	0.0557	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.0152	0.0507	CbGpPWpGaD
Bismuth Subsalicylate—Lethargy—Spironolactone—dilated cardiomyopathy	0.0146	0.0427	CcSEcCtD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.0145	0.0483	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0144	0.0481	CbGpPWpGaD
Bismuth Subsalicylate—Fluid overload—Lisinopril—dilated cardiomyopathy	0.013	0.0378	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet degranulation—VCL—dilated cardiomyopathy	0.0129	0.0431	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.0123	0.041	CbGpPWpGaD
Bismuth Subsalicylate—Heartburn—Lisinopril—dilated cardiomyopathy	0.0117	0.0342	CcSEcCtD
Bismuth Subsalicylate—Hearing impaired—Furosemide—dilated cardiomyopathy	0.0113	0.033	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Spironolactone—dilated cardiomyopathy	0.011	0.0323	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.0103	0.0343	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—dilated cardiomyopathy	0.0102	0.0339	CbGpPWpGaD
Bismuth Subsalicylate—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00961	0.0281	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00938	0.0274	CcSEcCtD
Bismuth Subsalicylate—TF—EPHB forward signaling—RAC1—dilated cardiomyopathy	0.00927	0.0309	CbGpPWpGaD
Bismuth Subsalicylate—Deafness—Furosemide—dilated cardiomyopathy	0.00872	0.0255	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Furosemide—dilated cardiomyopathy	0.00796	0.0232	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00783	0.0229	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.00778	0.0259	CbGpPWpGaD
Bismuth Subsalicylate—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00721	0.0211	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Spironolactone—dilated cardiomyopathy	0.00711	0.0207	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.00674	0.0225	CbGpPWpGaD
Bismuth Subsalicylate—Somnolence—Spironolactone—dilated cardiomyopathy	0.00626	0.0183	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Furosemide—dilated cardiomyopathy	0.00601	0.0175	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00588	0.0172	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00581	0.0169	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.00573	0.0191	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Spironolactone—dilated cardiomyopathy	0.0056	0.0163	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00557	0.0163	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet degranulation—CD36—dilated cardiomyopathy	0.00554	0.0184	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.00527	0.0176	CbGpPWpGaD
Bismuth Subsalicylate—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.0051	0.0149	CcSEcCtD
Bismuth Subsalicylate—Asthma—Lisinopril—dilated cardiomyopathy	0.00506	0.0148	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Furosemide—dilated cardiomyopathy	0.00503	0.0147	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Spironolactone—dilated cardiomyopathy	0.00499	0.0146	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00482	0.0141	CcSEcCtD
Bismuth Subsalicylate—Erythema—Furosemide—dilated cardiomyopathy	0.0047	0.0137	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Spironolactone—dilated cardiomyopathy	0.00466	0.0136	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Lisinopril—dilated cardiomyopathy	0.0046	0.0134	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Furosemide—dilated cardiomyopathy	0.0046	0.0134	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Spironolactone—dilated cardiomyopathy	0.00448	0.0131	CcSEcCtD
Bismuth Subsalicylate—Rash—Spironolactone—dilated cardiomyopathy	0.00444	0.013	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00444	0.013	CcSEcCtD
Bismuth Subsalicylate—Headache—Spironolactone—dilated cardiomyopathy	0.00441	0.0129	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00425	0.0124	CcSEcCtD
Bismuth Subsalicylate—Nausea—Spironolactone—dilated cardiomyopathy	0.00419	0.0122	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00405	0.0118	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Lisinopril—dilated cardiomyopathy	0.00403	0.0118	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00401	0.0134	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TTN—dilated cardiomyopathy	0.00401	0.0134	CbGpPWpGaD
Bismuth Subsalicylate—Confusional state—Furosemide—dilated cardiomyopathy	0.00387	0.0113	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00383	0.0112	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00378	0.011	CcSEcCtD
Bismuth Subsalicylate—PTGS2—S1P1 pathway—RAC1—dilated cardiomyopathy	0.00371	0.0124	CbGpPWpGaD
Bismuth Subsalicylate—Anorexia—Furosemide—dilated cardiomyopathy	0.00365	0.0107	CcSEcCtD
Bismuth Subsalicylate—Erythema—Lisinopril—dilated cardiomyopathy	0.00352	0.0103	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00348	0.0116	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—ACTN2—dilated cardiomyopathy	0.00348	0.0116	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00347	0.0116	CbGpPWpGaD
Bismuth Subsalicylate—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00345	0.0101	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Furosemide—dilated cardiomyopathy	0.00341	0.00995	CcSEcCtD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00338	0.0113	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00338	0.0113	CbGpPWpGaD
Bismuth Subsalicylate—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00333	0.00973	CcSEcCtD
Bismuth Subsalicylate—Pain—Furosemide—dilated cardiomyopathy	0.00328	0.00957	CcSEcCtD
Bismuth Subsalicylate—Constipation—Furosemide—dilated cardiomyopathy	0.00328	0.00957	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	0.00319	0.0106	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00316	0.00922	CcSEcCtD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00314	0.0105	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Furosemide—dilated cardiomyopathy	0.00305	0.00889	CcSEcCtD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.00304	0.0101	CbGpPWpGaD
Bismuth Subsalicylate—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00303	0.00885	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—VCL—dilated cardiomyopathy	0.00296	0.00985	CbGpPWpGaD
Bismuth Subsalicylate—Confusional state—Lisinopril—dilated cardiomyopathy	0.0029	0.00847	CcSEcCtD
Bismuth Subsalicylate—Oedema—Lisinopril—dilated cardiomyopathy	0.00288	0.0084	CcSEcCtD
Bismuth Subsalicylate—Infection—Lisinopril—dilated cardiomyopathy	0.00286	0.00834	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—dilated cardiomyopathy	0.0028	0.00933	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.00277	0.00923	CbGpPWpGaD
Bismuth Subsalicylate—Anorexia—Lisinopril—dilated cardiomyopathy	0.00274	0.008	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Furosemide—dilated cardiomyopathy	0.00271	0.00792	CcSEcCtD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.00264	0.00879	CbGpPWpGaD
Bismuth Subsalicylate—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00262	0.00766	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Lisinopril—dilated cardiomyopathy	0.00256	0.00746	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Furosemide—dilated cardiomyopathy	0.00254	0.0074	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00253	0.00739	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.0025	0.0073	CcSEcCtD
Bismuth Subsalicylate—Constipation—Lisinopril—dilated cardiomyopathy	0.00246	0.00718	CcSEcCtD
Bismuth Subsalicylate—Pain—Lisinopril—dilated cardiomyopathy	0.00246	0.00718	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.00246	0.00818	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Furosemide—dilated cardiomyopathy	0.00244	0.00712	CcSEcCtD
Bismuth Subsalicylate—Rash—Furosemide—dilated cardiomyopathy	0.00242	0.00706	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Furosemide—dilated cardiomyopathy	0.00242	0.00705	CcSEcCtD
Bismuth Subsalicylate—Headache—Furosemide—dilated cardiomyopathy	0.0024	0.00701	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00237	0.00692	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.00236	0.00785	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00235	0.00783	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.00231	0.00771	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Lisinopril—dilated cardiomyopathy	0.00229	0.00667	CcSEcCtD
Bismuth Subsalicylate—Nausea—Furosemide—dilated cardiomyopathy	0.00228	0.00665	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00227	0.00664	CcSEcCtD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.00224	0.00748	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Lisinopril—dilated cardiomyopathy	0.00204	0.00594	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.00202	0.00675	CbGpPWpGaD
Bismuth Subsalicylate—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00197	0.00574	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.00194	0.00647	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00191	0.00638	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Lisinopril—dilated cardiomyopathy	0.0019	0.00555	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00186	0.00621	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Lisinopril—dilated cardiomyopathy	0.00183	0.00534	CcSEcCtD
Bismuth Subsalicylate—Rash—Lisinopril—dilated cardiomyopathy	0.00181	0.00529	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00181	0.00529	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	0.00181	0.00603	CbGpPWpGaD
Bismuth Subsalicylate—Headache—Lisinopril—dilated cardiomyopathy	0.0018	0.00526	CcSEcCtD
Bismuth Subsalicylate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	0.00172	0.00574	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Lisinopril—dilated cardiomyopathy	0.00171	0.00499	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.00161	0.00535	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00157	0.00522	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.00156	0.00519	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.00153	0.00511	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.00152	0.00507	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00149	0.00498	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—ITGB1—dilated cardiomyopathy	0.00148	0.00495	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00145	0.00484	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.00142	0.00472	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00137	0.00455	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00132	0.00441	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	0.00127	0.00422	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—CD36—dilated cardiomyopathy	0.00127	0.00422	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00124	0.00414	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.00123	0.00409	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.00121	0.00404	CbGpPWpGaD
Bismuth Subsalicylate—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00121	0.00403	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	0.00121	0.00403	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—RAC1—dilated cardiomyopathy	0.00119	0.00397	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00119	0.00395	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00115	0.00384	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.00113	0.00376	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00108	0.00361	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.00104	0.00348	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	0.00101	0.00336	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00101	0.00335	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000961	0.0032	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000959	0.0032	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000933	0.00311	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000877	0.00292	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.000861	0.00287	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000832	0.00277	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000792	0.00264	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—RAF1—dilated cardiomyopathy	0.000791	0.00264	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	0.000741	0.00247	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TTN—dilated cardiomyopathy	0.00073	0.00243	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000685	0.00228	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000647	0.00216	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	0.000633	0.00211	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000632	0.00211	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000619	0.00206	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000615	0.00205	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000615	0.00205	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	0.000608	0.00203	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000597	0.00199	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000594	0.00198	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.00059	0.00197	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000586	0.00195	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000572	0.00191	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	0.00055	0.00183	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—VCL—dilated cardiomyopathy	0.000538	0.00179	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000514	0.00171	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—TAZ—dilated cardiomyopathy	0.000483	0.00161	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	0.00048	0.0016	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000471	0.00157	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000447	0.00149	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SDHA—dilated cardiomyopathy	0.000437	0.00146	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000422	0.0014	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	0.000416	0.00139	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	0.000391	0.0013	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—TAZ—dilated cardiomyopathy	0.000391	0.0013	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000388	0.00129	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000381	0.00127	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	0.000373	0.00124	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SDHA—dilated cardiomyopathy	0.000353	0.00118	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000336	0.00112	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000327	0.00109	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000294	0.000981	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.00028	0.000932	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	0.00027	0.000901	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NPPA—dilated cardiomyopathy	0.000267	0.00089	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000266	0.000888	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000266	0.000887	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000259	0.000865	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PSEN2—dilated cardiomyopathy	0.000259	0.000862	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000254	0.000845	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000234	0.000779	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CD36—dilated cardiomyopathy	0.000231	0.000768	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—RAC1—dilated cardiomyopathy	0.000217	0.000724	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000216	0.000718	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.00021	0.0007	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000189	0.00063	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	0.000149	0.000498	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CD36—dilated cardiomyopathy	0.000146	0.000485	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—RAF1—dilated cardiomyopathy	0.000144	0.00048	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AGT—dilated cardiomyopathy	0.000131	0.000437	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RAC1—dilated cardiomyopathy	0.00013	0.000433	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000125	0.000416	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GPX1—dilated cardiomyopathy	0.000119	0.000395	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CD36—dilated cardiomyopathy	0.000116	0.000385	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AGT—dilated cardiomyopathy	0.000104	0.000347	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GPX1—dilated cardiomyopathy	9.6e-05	0.00032	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CD36—dilated cardiomyopathy	9.35e-05	0.000312	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RAF1—dilated cardiomyopathy	8.62e-05	0.000287	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AGT—dilated cardiomyopathy	8.42e-05	0.000281	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—EGFR—dilated cardiomyopathy	5.91e-05	0.000197	CbGpPWpGaD
